Simm, Jaak
Humbeck, Lina
Zalewski, Adam
Sturm, Noe
Heyndrickx, Wouter
Moreau, Yves
Beck, Bernd
Schuffenhauer, Ansgar http://orcid.org/0000-0001-6385-0414
Funding for this research was provided by:
innovative medicines initiative (831472)
Article History
Received: 28 July 2021
Accepted: 22 November 2021
First Online: 7 December 2021
Declarations
:
: The authors declare that they have no competing interests. The authors AZ, NS, AS, WH, BB and LH did the work as employee of Amgen, Novartis, Janssen and Boehringer Ingelheim, respectively.